BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23139634)

  • 1. Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas.
    Wotschofsky Z; Liep J; Meyer HA; Jung M; Wagner I; Disch AC; Schaser KD; Melcher I; Kilic E; Busch J; Weikert S; Miller K; Erbersdobler A; Mollenkopf HJ; Jung K
    Int J Biol Sci; 2012; 8(10):1363-74. PubMed ID: 23139634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.
    Wotschofsky Z; Gummlich L; Liep J; Stephan C; Kilic E; Jung K; Billaud JN; Meyer HA
    PLoS One; 2016; 11(2):e0148746. PubMed ID: 26859141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
    Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
    J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
    He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
    PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1.
    Butz H; Szabó PM; Khella HW; Nofech-Mozes R; Patocs A; Yousef GM
    Oncotarget; 2015 May; 6(14):12543-57. PubMed ID: 26002553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma.
    Heinzelmann J; Henning B; Sanjmyatav J; Posorski N; Steiner T; Wunderlich H; Gajda MR; Junker K
    World J Urol; 2011 Jun; 29(3):367-73. PubMed ID: 21229250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma.
    Nakata W; Uemura M; Sato M; Fujita K; Jingushi K; Ueda Y; Kitae K; Tsujikawa K; Nonomura N
    Oncotarget; 2015 Aug; 6(25):21645-54. PubMed ID: 26046464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses.
    Khella HW; White NM; Faragalla H; Gabril M; Boazak M; Dorian D; Khalil B; Antonios H; Bao TT; Pasic MD; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Jewett MA; Yousef GM
    Tumour Biol; 2012 Feb; 33(1):131-40. PubMed ID: 22086373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC.
    Szabó Z; Szegedi K; Gombos K; Mahua C; Flaskó T; Harda K; Halmos G
    Urol Oncol; 2016 Dec; 34(12):533.e21-533.e27. PubMed ID: 27427222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 13. Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases.
    Wotschofsky Z; Meyer HA; Jung M; Fendler A; Wagner I; Stephan C; Busch J; Erbersdobler A; Disch AC; Mollenkopf HJ; Jung K
    Anal Biochem; 2011 Oct; 417(2):233-41. PubMed ID: 21741950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-200c Targets CDK2 and Suppresses Tumorigenesis in Renal Cell Carcinoma.
    Wang X; Chen X; Han W; Ruan A; Chen L; Wang R; Xu Z; Xiao P; Lu X; Zhao Y; Zhou J; Chen S; Du Q; Yang H; Zhang X
    Mol Cancer Res; 2015 Dec; 13(12):1567-77. PubMed ID: 26248649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies.
    Qi Y; Wang L; Wang K; Peng Z; Ma Y; Zheng Z; Shang D; Xu W; Zheng J
    Biomed Pharmacother; 2019 Mar; 111():821-834. PubMed ID: 30616081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.
    White NM; Khella HW; Grigull J; Adzovic S; Youssef YM; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Jewett MA; Evans AJ; Gabril M; Yousef GM
    Br J Cancer; 2011 Nov; 105(11):1741-9. PubMed ID: 22033272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
    Moynihan MJ; Sullivan TB; Burks E; Schober J; Calabrese M; Fredrick A; Kalantzakos T; Warrick J; Canes D; Raman JD; Rieger-Christ K
    Urol Oncol; 2020 Oct; 38(10):799.e11-799.e22. PubMed ID: 32534961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
    Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
    Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA-9 and MiRNA-200a distinguish hemangioblastomas from metastatic clear cell renal cell carcinomas in the CNS.
    Venneti S; Boateng LA; Friedman JR; Baldwin DA; Tobias JW; Judkins AR; Mourelatos Z; Lal P
    Brain Pathol; 2012 Jul; 22(4):522-9. PubMed ID: 22082152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.